These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 20441769)

  • 1. Mitochondrial dysfunction in autism spectrum disorders: cause or effect?
    Palmieri L; Persico AM
    Biochim Biophys Acta; 2010; 1797(6-7):1130-7. PubMed ID: 20441769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1.
    Palmieri L; Papaleo V; Porcelli V; Scarcia P; Gaita L; Sacco R; Hager J; Rousseau F; Curatolo P; Manzi B; Militerni R; Bravaccio C; Trillo S; Schneider C; Melmed R; Elia M; Lenti C; Saccani M; Pascucci T; Puglisi-Allegra S; Reichelt KL; Persico AM
    Mol Psychiatry; 2010 Jan; 15(1):38-52. PubMed ID: 18607376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial dysfunction in autism.
    Legido A; Jethva R; Goldenthal MJ
    Semin Pediatr Neurol; 2013 Sep; 20(3):163-75. PubMed ID: 24331358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox metabolism abnormalities in autistic children associated with mitochondrial disease.
    Frye RE; Delatorre R; Taylor H; Slattery J; Melnyk S; Chowdhury N; James SJ
    Transl Psychiatry; 2013 Jun; 3(6):e273. PubMed ID: 23778583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autism and mitochondrial disease.
    Haas RH
    Dev Disabil Res Rev; 2010; 16(2):144-53. PubMed ID: 20818729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder.
    Frye RE; Melnyk S; Macfabe DF
    Transl Psychiatry; 2013 Jan; 3(1):e220. PubMed ID: 23340503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fever plus mitochondrial disease could be risk factors for autistic regression.
    Shoffner J; Hyams L; Langley GN; Cossette S; Mylacraine L; Dale J; Ollis L; Kuoch S; Bennett K; Aliberti A; Hyland K
    J Child Neurol; 2010 Apr; 25(4):429-34. PubMed ID: 19773461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial disorders.
    Zeviani M; Carelli V
    Curr Opin Neurol; 2007 Oct; 20(5):564-71. PubMed ID: 17885446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Autism, epilepsy and mitochondrial disease: points of contact].
    García-Peñas JJ
    Rev Neurol; 2008; 46 Suppl 1():S79-85. PubMed ID: 18302129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mitochondrial aspartate/glutamate carrier AGC1 and calcium homeostasis: physiological links and abnormalities in autism.
    Napolioni V; Persico AM; Porcelli V; Palmieri L
    Mol Neurobiol; 2011 Aug; 44(1):83-92. PubMed ID: 21691713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of mitochondria to common disorders.
    Enns GM
    Mol Genet Metab; 2003; 80(1-2):11-26. PubMed ID: 14567954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of mitochondrial dysfunction in Alzheimer's disease.
    Castellani R; Hirai K; Aliev G; Drew KL; Nunomura A; Takeda A; Cash AD; Obrenovich ME; Perry G; Smith MA
    J Neurosci Res; 2002 Nov; 70(3):357-60. PubMed ID: 12391597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial dysfunction in Autism Spectrum Disorder: clinical features and perspectives.
    Hollis F; Kanellopoulos AK; Bagni C
    Curr Opin Neurobiol; 2017 Aug; 45():178-187. PubMed ID: 28628841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial disease in autism spectrum disorder patients: a cohort analysis.
    Weissman JR; Kelley RI; Bauman ML; Cohen BH; Murray KF; Mitchell RL; Kern RL; Natowicz MR
    PLoS One; 2008; 3(11):e3815. PubMed ID: 19043581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial dysfunction as a neurobiological subtype of autism spectrum disorder: evidence from brain imaging.
    Goh S; Dong Z; Zhang Y; DiMauro S; Peterson BS
    JAMA Psychiatry; 2014 Jun; 71(6):665-71. PubMed ID: 24718932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial dysfunction: a neglected component of skin diseases.
    Feichtinger RG; Sperl W; Bauer JW; Kofler B
    Exp Dermatol; 2014 Sep; 23(9):607-14. PubMed ID: 24980550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain autoantibodies in autism spectrum disorder.
    Elamin NE; Al-Ayadhi LY
    Biomark Med; 2014; 8(3):345-52. PubMed ID: 24712424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures.
    Rossignol DA; Frye RE
    Mol Psychiatry; 2012 Apr; 17(4):389-401. PubMed ID: 22143005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe nigrostriatal degeneration without clinical parkinsonism in patients with polymerase gamma mutations.
    Tzoulis C; Tran GT; Schwarzlmüller T; Specht K; Haugarvoll K; Balafkan N; Lilleng PK; Miletic H; Biermann M; Bindoff LA
    Brain; 2013 Aug; 136(Pt 8):2393-404. PubMed ID: 23625061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis.
    Rossignol DA; Frye RE
    Mol Psychiatry; 2012 Mar; 17(3):290-314. PubMed ID: 21263444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.